Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus (Previously: Methylation in Cancer Progression of Barrett's Esophagus

NCT00431756 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00431756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00431756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus (Previously: Methylation in Cancer Progression of Barrett's Esophagus
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Active, not recruiting
Start date
May 1, 2002
Completion date
August 31, 2027
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, esophageal neoplasm, gastroesophageal reflux